ISRCTN69805695CompletedPhase 4
Carbetocin versus oxytocin for the prevention of post-partum hemorrhage in caesarean section: a randomised controlled trial
Beacon Pharmaceuticals Ltd (Bangladesh)0 sites64 target enrollmentStarted: April 20, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 64
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- Female
Inclusion Criteria
- •Women with a single pregnancy undergoing cesarean delivery at term
Exclusion Criteria
- •1. Placenta praevia
- •2. Multiple gestations
- •3. Placental abruption
- •4. Hypertensive disorders in pregnancy
- •5. Preeclampsia
- •6. Cardiac, renal or liver diseases
- •7. Epilepsy
- •8. Women with history of hypersensitivity to carbetocin according to the Br National Formulary
Investigators
Similar Trials
Not yet recruiting
Unknown
A study comparing Carbetocin and oxytocin for prevention of post partum hemorrhage following vaginal deliveryCTRI/2024/04/065975Dr.Saranya,Postgraduate in Obstetrics and gynaecology
Not yet recruiting
Phase 4
Efficacy of Carbetocin vs Oxytocin for the prevention of postpartum hemorrhage in high risk casesCTRI/2024/07/070664DrBhat Janvi Santosh
Not yet recruiting
Phase 3
Comparison of Carbetocin vs Oxytocin for prevention of haemorrhage after delivery in women undergoing Caesarean sectioCTRI/2022/06/043237IQ City Medical College Hospital
Recruiting
Not Applicable
Comparing of effectiveness carbetocin and oxytocin in reducing bleeding due to child delivery.CTRI/2022/10/046872Department of Obstetrics and Gynaecology
Not yet recruiting
Phase 3
Carbetocin vs Oxytocin for prevention of blood loss after normal vaginal deliveryCTRI/2023/06/053901Maharaja Agrasen Medical College, Agroha,Hisar